• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450

Recent Advances in the Study of 1-(2,4-Dichloro-1,3-thiazol-5-yl)methanamine Hydrochloride (CAS: 2694744-99-3)

1-(2,4-Dichloro-1,3-thiazol-5-yl)methanamine hydrochloride (CAS: 2694744-99-3) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug discovery, particularly as a building block for the synthesis of novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, focusing on its chemical properties, biological activities, and potential therapeutic applications.

Recent literature highlights the role of 1-(2,4-Dichloro-1,3-thiazol-5-yl)methanamine hydrochloride in the development of small-molecule inhibitors targeting various enzymes and receptors. Its unique structural features, including the dichlorothiazole moiety, make it a valuable scaffold for medicinal chemistry. Studies have demonstrated its utility in the synthesis of compounds with antimicrobial, antiviral, and anticancer properties. For instance, derivatives of this compound have shown promising activity against resistant bacterial strains and certain types of cancer cells.

One of the key advancements in the study of this compound is its application in the design of kinase inhibitors. Kinases are critical targets in the treatment of various diseases, including cancer and inflammatory disorders. Researchers have successfully incorporated 1-(2,4-Dichloro-1,3-thiazol-5-yl)methanamine hydrochloride into kinase inhibitor scaffolds, resulting in compounds with enhanced selectivity and potency. These findings underscore the compound's potential as a versatile tool in drug discovery.

In addition to its role in kinase inhibition, recent studies have explored the compound's interactions with other biological targets. For example, it has been investigated as a modulator of G-protein-coupled receptors (GPCRs), which are involved in a wide range of physiological processes. Preliminary results suggest that derivatives of this compound may exhibit selective binding to specific GPCR subtypes, opening new avenues for the development of targeted therapies.

The synthesis and characterization of 1-(2,4-Dichloro-1,3-thiazol-5-yl)methanamine hydrochloride have also been refined in recent years. Improved synthetic routes have been developed to enhance yield and purity, facilitating its use in large-scale pharmaceutical production. Analytical techniques such as NMR spectroscopy and mass spectrometry have been employed to confirm the compound's structure and purity, ensuring its suitability for further research and development.

Despite these advancements, challenges remain in the optimization of this compound for clinical use. Issues such as bioavailability, metabolic stability, and toxicity need to be addressed through further structural modifications and preclinical studies. However, the progress made thus far highlights the compound's potential as a cornerstone in the development of next-generation therapeutics.

In conclusion, 1-(2,4-Dichloro-1,3-thiazol-5-yl)methanamine hydrochloride (CAS: 2694744-99-3) represents a promising candidate for drug discovery, with applications spanning multiple therapeutic areas. Ongoing research is expected to uncover new opportunities for its use, paving the way for innovative treatments for various diseases. This brief provides a snapshot of the current state of research, emphasizing the compound's versatility and potential impact on the pharmaceutical industry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)